Showing results (101-110 of 872) with videos related to

Sort By:
Pageof 88
Cytokine & Growth Factor Reviews|June 17, 2020
IL-36 in chronic inflammation and cancerMarkus F Neurath
Therapeutic Advances in Gastroenterology|October 26, 2020
Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitisIngo Ganzleben, Carol Geppert, Lourdes Osaba, et al.
Journal of Crohn'S & Colitis|August 19, 2020
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammationKatharina Gerlach, Kristina Lechner, Vanessa Popp, et al.
The Journal of Allergy and Clinical Immunology|June 17, 2015
Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free dietBharani Srinivasan, Margarete Focke-Tejkl, Milena Weber, et al.
Therapeutic Advances in Gastroenterology|July 5, 2022
Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitisLaura Besendorf, Tanja M Müller, Carol-Immanuel Geppert, et al.
BMC Gastroenterology|October 24, 2015
High-definition endoscopy with digital chromoendoscopy for histologic prediction of distal colorectal polypsTimo Rath, Gian E Tontini, Andreas Nägel, et al.
Inflammatory Bowel Diseases|May 23, 2018
Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-sMarie-Theres Binder, Emily Becker, Maximilian Wiendl, et al.
Therapeutic Advances in Gastroenterology|January 2, 2024
Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitisFrancesco Vitali, Timo Rath, Entcho Klenske, et al.
Archivum Immunologiae Et Therapiae Experimentalis|August 27, 2014
Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitisStefanie Steiner, Carolin Daniel, Anika Fischer, et al.
Pageof 88